AR remains important in the development and progression of prostate cancer, and the majority of androgen‐independent or hormone‐refractory prostate cancers express AR (Heinlein and Chang, 2004), which in part is associated with the extensive re‐programming of its transcriptional activity (Pomerantz et al., 2015). The gene discussed is AR; the disease is prostate carcinoma.